Cd13–/– mice treated with a B1R antagonist exhibited a reduction in arthritis development compared with WT mice, but a significant decrease in arthritis did not appear until day 8, suggesting the importance of both ligands of B1R in arthritis development in this model, bradykinin early and sCD13 later. The gene discussed is ANPEP; the disease is arthritic joint disease.